Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

M.Video-Eldorado to open 100 new stores in 2024

1/16/25 MVID

Nornickel to invest ₽25 billion in the Severny mine stripping project

1/15/25 GMKN

Number of private investors on Moscow Exchange exceeded 35 million

1/15/25 MOEX

NKHP to break grain transshipment record in 2024

1/15/25 NKHP

VK prepares Skillbox for IPO

1/15/25 VKCO

Kamaz in 2024 sold 24.5 thousand units of vehicles in 2024

1/15/25 KMAZ

UTair passenger traffic by airplane in 2024 increased by 5.7%

1/15/25 UTAR

Ozon entered the car leasing market

1/15/25 OZON

Fix Price plans to open at least 700 new stores in 2025

1/15/25 FIXP

Positive Technologies has distributed shares to contributors

1/15/25 POSI